Semler Scientific (NASDAQ:SMLR) Releases Quarterly Earnings Results, Beats Estimates By $0.35 EPS

Semler Scientific (NASDAQ:SMLR) announced its quarterly earnings results on Monday. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35, Zacks reports. The company had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.93%.

Semler Scientific Stock Performance

Shares of SMLR traded down $1.82 on Thursday, hitting $38.29. 120,368 shares of the stock traded hands, compared to its average volume of 191,931. Semler Scientific has a one year low of $20.88 and a one year high of $53.38. The company has a market capitalization of $267.72 million, a PE ratio of 19.57 and a beta of 0.92. The business has a 50 day simple moving average of $26.37 and a 200 day simple moving average of $28.81.

Insider Buying and Selling

In related news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total transaction of $283,500.00. Following the transaction, the chief executive officer now owns 60,220 shares in the company, valued at $1,707,237. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 30.20% of the stock is owned by corporate insiders.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.